Drug Profile
Nicotine orally-dissolving film - NAL Pharma
Alternative Names: NAL 2762Latest Information Update: 26 May 2022
Price :
$50
*
At a glance
- Originator NAL Pharma
- Class Alkaloids; Analgesics; Drug withdrawal therapies; Nicotine replacement therapy; Pyridines; Small molecules
- Mechanism of Action Nicotinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Clinical Phase Unknown Smoking withdrawal
Most Recent Events
- 26 May 2022 Nicotine orally-dissolving film is still in clinical trials for smoking-withdrawal (NAL Pharma pipeline, May 2022)
- 28 Oct 2019 No recent reports of development identified for clinical-Phase-Unknown development in Smoking-withdrawal in Unknown (Sublingual, Film)
- 07 Sep 2016 Chemical structure information added